Although new HIV infections in African American women have decreased, this population still constitutes the over half of all new HIV infections in women. Risk-reduction interventions and advancements in antiretroviral therapies have helped HIV-positive persons live longer. However, there are lags in care linkages and retention. Medication adherence is an important aspect of enhancing quality of and prolonging lives of persons living with HIV/AIDS. While studies have explored barriers and facilitators to medication adherence, gaps in the literature related to adherence for high-risk populations remain. By using narrative inquiry and the Health Belief Model, this exploratory study sought to gain insight on facilitators of and barriers to medication adherence among African American women who have been HIV positive for 10 or more years. The women discussed personal experiences and cues to action that help them remain adherent. Additional studies testing interventions designed specifically for long-term survivors may be advantageous within public health.

中文翻译：

---

艾滋病毒阳性10年或以上的非洲裔美国妇女中的服药依从性

尽管非洲裔美国妇女的新的艾滋病毒感染人数有所减少，但这一人口仍然占妇女所有新的艾滋病毒感染人数的一半以上。降低风险的干预措施和抗逆转录病毒疗法的发展已帮助艾滋病毒抗体阳性的人延长了寿命。但是，护理联系和保留方面存在滞后。依从药物治疗是提高艾滋病毒/艾滋病患者的质量并延长其寿命的重要方面。尽管研究已经探索了药物依从性的障碍和促进因素，但与高危人群依从性相关的文献仍存在空白。通过使用叙述性询问和“健康信念模型”，这项探索性研究旨在了解艾滋病毒呈阳性10年或以上的非洲裔美国妇女中药物依从性的促进因素和障碍。这些妇女讨论了个人经验和采取行动的暗示，以帮助她们保持执着。测试专门针对长期幸存者设计的干预措施的其他研究可能对公共卫生有利。